Banco de Chile Ret. on equity
What is the Ret. on equity of Banco de Chile?
The Ret. on equity of Banco de Chile is 30.74%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Finance sector on NYSE compared to Banco de Chile
What does Banco de Chile do?
somos una corporación líder con una prestigiosa tradición de negocios. nuestro propósito es proveer servicios financieros de excelencia, con soluciones creativas y efectivas para cada segmento de clientes, que aseguren la permanente creación de valor para nuestros accionistas. queremos ser el mejor banco para nuestros clientes, el mejor lugar para trabajar, la mejor inversión para nuestros accionistas.
Companies with ret. on equity similar to Banco de Chile
- Gufic Biosciences has Ret. on equity of 30.70%
- Coheris SA has Ret. on equity of 30.71%
- Vedanta Ltd has Ret. on equity of 30.71%
- First Responder Technologies has Ret. on equity of 30.72%
- Ringmetall SE has Ret. on equity of 30.72%
- Pro Real Estate Investment Trust has Ret. on equity of 30.74%
- Banco de Chile has Ret. on equity of 30.74%
- Kforce has Ret. on equity of 30.75%
- Guess has Ret. on equity of 30.75%
- Western Pacific Trust has Ret. on equity of 30.77%
- GlaxoSmithKline Plc has Ret. on equity of 30.78%
- GlaxoSmithKline Plc has Ret. on equity of 30.78%
- GlaxoSmithKline Plc has Ret. on equity of 30.78%